GSK plc

CIK 000113139939 companiesBRENTFORD MIDDLESEX, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001131399

Recent Transactions

50 trades

Purchase
Wave Life Sciences Ltd.$WVE
Ordinary Shares
2025-12-11$19.00/sh+1,470,000→ 18,245,691 total
Purchase
Wave Life Sciences Ltd.$WVE
Ordinary Shares
2024-09-27$8.00/sh+2,791,930→ 16,775,691 total
Purchase
Wave Life Sciences Ltd.$WVE
Ordinary Shares
2023-12-07$5.00/sh+3,300,000→ 13,983,761 total
Other
Theravance Biopharma, Inc.$TBPH
Exchangeable Senior Notes due 2023
2022-09-16→ 0 total
Other
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2022-09-16$9.75/sh−9,644,807→ 0 total
Conversion
CVRx, Inc.$CVRX
Common Stock
2021-07-02+14,917→ 61,212 total
Conversion
CVRx, Inc.$CVRX
Series F-2 Preferred Stock
2021-07-02−1,081,434→ 0 total
Conversion
CVRx, Inc.$CVRX
Series D-2 Preferred Stock
2021-07-02−589,939→ 0 total
Conversion
CVRx, Inc.$CVRX
Common Stock
2021-07-02+27,345→ 96,937 total
Purchase
CVRx, Inc.$CVRX
Common Stock
2021-07-02$18.00/sh+275,000→ 1,007,583 total
Conversion
CVRx, Inc.$CVRX
Common Stock
2021-07-02+12,979→ 46,295 total
Conversion
CVRx, Inc.$CVRX
Common Stock
2021-07-02+8,380→ 69,592 total
Conversion
CVRx, Inc.$CVRX
Common Stock
2021-07-02+1,505→ 33,316 total
Conversion
CVRx, Inc.$CVRX
Series G Preferred Stock
2021-07-02−10,055,408→ 0 total
Conversion
CVRx, Inc.$CVRX
Series C-2 Preferred Stock
2021-07-02−513,312→ 0 total
Conversion
CVRx, Inc.$CVRX
Series B-2 Preferred Stock
2021-07-02−59,527→ 0 total
Conversion
CVRx, Inc.$CVRX
Series E-2 Preferred Stock
2021-07-02−331,399→ 0 total
Conversion
CVRx, Inc.$CVRX
Common Stock
2021-07-02+635,646→ 732,583 total
Conversion
Lyell Immunopharma, Inc.$LYEL
Series AA Preferred Stock
2021-06-21−30,253,189→ 0 total
Conversion
Lyell Immunopharma, Inc.$LYEL
Common Stock
2021-06-21+30,253,189→ 30,253,189 total
Sale
Innoviva, Inc.$INVA
Common Stock
2021-05-20$12.25/sh−32,005,260→ 0 total
Conversion
Decibel Therapeutics, Inc.
Series D Preferred Stock
2021-02-17−1,737,619→ 0 total
Purchase
Decibel Therapeutics, Inc.
Common Stock
2021-02-17$18.00/sh+150,000→ 1,183,663 total
Conversion
Decibel Therapeutics, Inc.
Common Stock
2021-02-17+458,487→ 458,487 total
Conversion
Decibel Therapeutics, Inc.
Common Stock
2021-02-17+327,852→ 1,033,663 total
Conversion
Decibel Therapeutics, Inc.
Common Stock
2021-02-17+247,324→ 705,811 total
Conversion
Decibel Therapeutics, Inc.
Series A Preferred Stock
2021-02-17−7,119,850→ 0 total
Conversion
Decibel Therapeutics, Inc.
Series C Preferred Stock
2021-02-17−3,125,000→ 0 total
Purchase
GENOCEA BIOSCIENCES, INC.
Common Stock
2020-07-24$2.25/sh+1,260,504→ 4,626,389 total
Purchase
GENOCEA BIOSCIENCES, INC.
Warrant
2020-07-24$0.13/sh+1,260,504→ 1,260,504 total
Purchase
Pandion Therapeutics, Inc.
Common Stock
2020-07-21$18.00/sh+361,111→ 2,248,304 total
Conversion
Pandion Therapeutics, Inc.
Series B Preferred Stock
2020-07-21−1,776,980→ 0 total
Conversion
Pandion Therapeutics, Inc.
Common Stock
2020-07-21+348,469→ 1,887,193 total
Conversion
Pandion Therapeutics, Inc.
Series A Preferred Stock
2020-07-21−7,846,554→ 0 total
Conversion
Pandion Therapeutics, Inc.
Common Stock
2020-07-21+1,538,724→ 1,538,724 total
Award
Pandion Therapeutics, Inc.
Stock Option (right to buy)
2020-07-17+13,997→ 13,997 total
Sale
BICYCLE THERAPEUTICS PLC$BCYC
Common Stock
2020-07-15$19.25/sh−78→ 1,910,531 total
Sale
BICYCLE THERAPEUTICS PLC$BCYC
Common Stock
2020-07-15$19.40/sh−3,069→ 1,910,609 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2020-07-14+10,700→ 10,700 total
Conversion
Nkarta, Inc.$NKTX
Common Stock
2020-07-14+79,090→ 79,090 total
Purchase
Nkarta, Inc.$NKTX
Common Stock
2020-07-14$18.00/sh+833,333→ 3,150,732 total
Sale
BICYCLE THERAPEUTICS PLC$BCYC
Common Stock
2020-07-14$19.27/sh−1,597→ 1,913,678 total
Conversion
Nkarta, Inc.$NKTX
Series A Preferred Stock
2020-07-14−292,663→ 0 total
Conversion
Nkarta, Inc.$NKTX
Common Stock
2020-07-14+1,712,810→ 2,317,399 total
Conversion
Nkarta, Inc.$NKTX
Common Stock
2020-07-14+525,499→ 604,589 total
Conversion
Nkarta, Inc.$NKTX
Series A Preferred Stock
2020-07-14−1,994,348→ 0 total
Conversion
Nkarta, Inc.$NKTX
Series B Preferred Stock
2020-07-14−6,337,403→ 0 total
Sale
Theravance Biopharma, Inc.$TBPH
Exchangeable Note
2020-06-22→ 0 total
Purchase
Turning Point Therapeutics, Inc.
Common Stock
2020-05-21$60.00/sh+83,333→ 2,253,660 total
Sale
Progyny, Inc.$PGNY
Common Stock
2020-05-20$25.75/sh−4,000,000→ 6,238,244 total

Companies

Recent Filings

Address

980 GREAT WEST ROAD

BRENTFORD MIDDLESEX, X0, TW8 9GS

View on SEC.gov